Robert Abramowitz

Title: The Innovative Contributions of Robert Abramowitz

Introduction

Robert Abramowitz is a notable inventor based in West Windsor, NJ (US). He has made significant contributions to the pharmaceutical field, particularly in drug delivery systems. With a total of 2 patents, his work has had a meaningful impact on the treatment of retroviral infections.

Latest Patents

Abramowitz's latest patents include "Sustained Release Beadlets Containing Stavudine" and "Colonic Drug Delivery System." The first patent describes extended dosage forms of stavudine, which are designed to provide blood levels of the drug over approximately 24 hours. This is achieved through beadlets formed by extrusion-spheronization and coated with both a seal coating and a modified release coating. The formulation includes a dry blend of stavudine, a spheronizing agent, a suitable diluent, and magnesium stearate, which stabilizes stavudine against degradation. The second patent outlines a three-component pharmaceutical formulation that ensures over 80% of the active substance is released in the large intestine. This innovative approach utilizes microcrystalline cellulose, a pH-sensitive polymer, and an enteric coating to enhance drug delivery.

Career Highlights

Robert Abramowitz is currently associated with Bristol-Myers Squibb Company, where he continues to advance pharmaceutical innovations. His work focuses on developing effective drug delivery systems that improve patient outcomes.

Collaborations

Throughout his career, Abramowitz has collaborated with esteemed colleagues such as Nemichand B Jain and Sunanda A Ranadive. These partnerships have contributed to the success of his innovative projects.

Conclusion

Robert Abramowitz's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to improving drug delivery systems. His work continues to influence the treatment of retroviral infections and showcases the importance of innovation in healthcare.